IQV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
IQVIA Holdings Inc (IQV) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. Despite short-term volatility and AI-related concerns, the company's strong financial performance, positive congressional trading sentiment, and long-term growth potential in the clinical trial and healthcare analytics market make it a solid choice.
The MACD is positive and expanding (3.101), indicating bullish momentum. RSI is neutral at 59.722, and moving averages are converging, signaling no clear trend but potential for upward movement. The stock is trading near the R1 resistance level of 180.045, with support at 171.159. Overall, technical indicators suggest a cautiously optimistic outlook.
Congress members have made 4 purchase transactions in the last 90 days, indicating confidence in the stock.
Strong Q4 financial performance with revenue up 10.26% YoY, net income up 17.62% YoY, and EPS up 23.55% YoY.
Analysts maintain mostly positive ratings, with price targets ranging from $174 to $250, reflecting long-term growth potential.
Advancements in AI technology and healthcare accessibility highlighted in the company's sustainability report.
Hedge funds and insiders are selling heavily, with insider selling up 1004.81% in the last month.
Concerns about AI disruption in the CRO market have led to reduced price targets and some investor uncertainty.
Gross margin dropped by 5.60% YoY in Q4, which could indicate cost pressures.
In Q4 2025, IQVIA reported strong financial growth: Revenue increased by 10.26% YoY to $4.36 billion, net income rose by 17.62% YoY to $514 million, and EPS grew by 23.55% YoY to 2.99. However, gross margin declined by 5.60% YoY to 25.64%, which may require monitoring.
Analysts maintain mostly positive ratings, with several 'Outperform' and 'Buy' ratings. Price targets have been adjusted downward recently due to AI concerns, but the median target remains significantly above the current price, reflecting long-term optimism.
